HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Cardio-Oncology
Cardio-Oncology
Cancer treatments, despite their transformative potential, often come with unintended cardiovascular risks. Cardio-oncology focuses on understanding and mitigating these risks through a combination of cutting-edge diagnostics and personalized care. By using technologies like cardiac MRI and strain imaging, clinicians can detect early signs of heart stress caused by therapies such as radiation or targeted treatments. This collaborative field not only emphasizes prevention but also explores innovative therapeutics to repair heart damage. As survival rates improve, the integration of cardio-oncology ensures long-term health, enabling patients to overcome cancer without compromising cardiovascular wellness.
Committee Members
Yochai Birnbaum
Baylor College of Medicine, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States Cardio 2026 Speakers
Yochai Birnbaum
Baylor College of Medicine, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States
Narendra Kumar
HeartbeatsZ Academy, United KingdomSubmit your abstract Today
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : Finite-Element and Electromagnetic Cardio-Vascular Simulation for Drug Testing, Monitoring, and Safety Projection Using Bansal B–Bio Framework
Abhishek Bansal, New Era Consultancy Services, India
Title : Lipid and High-Density Lipoprotein (HDL) Subfraction Changes in Premenopausal and Postmenopausal Women with Breast Cancer Receiving Hormonal Therapy
Sofra Maria, Aretaieion University Hospital, Greece